TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18851851

Group type: EXPERIMENTAL
Intervention: Quantitative index (QI; 0-10)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Qualitative evaluation (QE; poor, fair, good, excellent)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall adequacy assessment (OAA; inadequate, adequate)
Number of subjects: 40
Study: 16462661

Group type: EXPERIMENTAL
Intervention: Cefpodoxime-proxetil (200 mg bid for 5 days)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanic acid (1 g/125 mg bid for 8 days)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Cefpodoxime-proxetil
Number of subjects: 512

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 512
Study: 15586136

Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention
Number of subjects: 137

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 137
Study: 11760163

Group type: COMPARATOR
Intervention: Ceftazidime (2 g t.i.d.) + Amikacin (15 mg/kg/o.d.)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Cefepime (2 g b.i.d.) + Amikacin (15 mg/kg/o.d.)
Number of subjects: 208
Study: 9289668

Group type: EXPERIMENTAL
Intervention: Knowledge of Mediterranean anemia
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Discussion with doctor about Mediterranean anemia
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Discussion with gynecologist about Mediterranean anemia
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Knowledge of hemoglobinophoresis
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Awareness of hemoglobinophoresis test
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Informed about Mediterranean anemia before age 20
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Informed about Mediterranean anemia between ages 20 and 35
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Correct response to risk of severe blood pathology in carriers
Number of subjects: 124
Study: 8358903

Group type: EXPERIMENTAL
Intervention: Collared prostheses
Number of subjects: 84

Group type: COMPARATOR
Intervention: Collarless prostheses
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Collared prostheses with poor bone contact
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Collared prostheses with good bone contact
Number of subjects: 84

Group type: COMPARATOR
Intervention: Collarless group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Collared group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Collared and collarless prostheses
Number of subjects: 84
Study: 3085430

Group type: EXPERIMENTAL
Intervention: Alfentanil 15 micrograms/kg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Diazepam 5 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Droperidol 5 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Etomidate 10 mg
Number of subjects: 10
Study: 29783091

Group type: EXPERIMENTAL
Intervention: MIND-S (home-based dementia care coordination)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Augmented usual care group
Number of subjects: 304
Study: 26487578

Group type: EXPERIMENTAL
Intervention: LV5FU2
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: LV5FU2-irinotecan
Number of subjects: 282

Group type: COMPARATOR
Intervention: simplified LV5FU2
Number of subjects: 282

Group type: COMPARATOR
Intervention: FOLFIRI
Number of subjects: 282
Study: 24980836

Group type: EXPERIMENTAL
Intervention: 8-week yoga intervention (n=15), consisting of a weekly 90-minute teacher-led class and a 40-minute daily session delivered by DVD
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 8-week yoga intervention (n=15)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care wait-listed control group (n=13)
Number of subjects: 28
Study: 23268423

Group type: EXPERIMENTAL
Intervention: Laparoscopic ventriculoperitoneal shunt with temporary external drainage
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional ventriculoperitoneal shunt
Number of subjects: 52
Study: 20723019

Group type: EXPERIMENTAL
Intervention: Simplified technique (S)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Traditional academic standard (T)
Number of subjects: 122
Study: 19071990

Group type: EXPERIMENTAL
Intervention: Salient distractor in visual search with highly similar target and distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salient distractor in visual search with highly dissimilar target and distractors
Number of subjects: 0
Study: 16150255

Group type: EXPERIMENTAL
Intervention: Human papillomavirus deoxyribonucleic acid testing by general primer 5+/6+ polymerase chain reaction
Number of subjects: 12527

Group type: COMPARATOR
Intervention: Mock testing
Number of subjects: 12527
Study: 14716420

Group type: EXPERIMENTAL
Intervention: Hapavax-Gene vaccine (10 microgram doses for ages 10-19, 20 microgram doses for ages over 19) administered intramuscularly in three doses: day 0, after 30 days, and after 180 days.
Number of subjects: 67
Study: 11774102

Group type: EXPERIMENTAL
Intervention: HP-CVVH (Continuous Venovenous Hemofiltration)
Number of subjects: 80

Group type: COMPARATOR
Intervention: HP (Hemoperfusion)
Number of subjects: 80
Study: 9723053

Group type: EXPERIMENTAL
Intervention: Dissecting microscope
Number of subjects: 41

Group type: COMPARATOR
Intervention: Magnifying loupes with transillumination
Number of subjects: 41
Study: 8155439

Group type: EXPERIMENTAL
Intervention: suxamethonium 1.5 mg kg‐1
Number of subjects: 80

Group type: COMPARATOR
Intervention: alfentanil 15 micrograms kg‐1
Number of subjects: 80
Study: 3345041

Group type: EXPERIMENTAL
Intervention: Bradykinin challenge
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 8
Study: 31278095

Group type: EXPERIMENTAL
Intervention: Exercise group performing a 12-week, supervised, high-intensity interval training programme (3 sessions/week for 28-40 min/session)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 66
Study: 27779368

Group type: EXPERIMENTAL
Intervention: Active group (peripheral nerve stimulation of the occipital nerves)
Number of subjects: 20
Study: 26031301

Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Single Bond Universal
Number of subjects: 44
Study: 23273365

Group type: EXPERIMENTAL
Intervention: Transbond LR composite paste without liquid resin (test group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transbond LR composite paste with liquid resin (control group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Test group
Number of subjects: 40
Study: 21787487

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PRP + collagen sponge
Number of subjects: 30

Group type: COMPARATOR
Intervention: Collagen membrane (GTR)
Number of subjects: 30
Study: 20112574

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 65

Group type: COMPARATOR
Intervention: Infrared therapy
Number of subjects: 65
Study: 17322819

Group type: EXPERIMENTAL
Intervention: Schools with iodinator
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Schools without iodinator
Number of subjects: 1100
Study: 15306594

Group type: EXPERIMENTAL
Intervention: PhiCal test (calprotectin level > or =50 microg/g)
Number of subjects: 2321

Group type: COMPARATOR
Intervention: FlexSure OBT (human haemoglobin immunochemical FOBT)
Number of subjects: 2321

Group type: EXPERIMENTAL
Intervention: PhiCal test
Number of subjects: 2321

Group type: COMPARATOR
Intervention: FlexSure OBT
Number of subjects: 2321
Study: 11283130

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (5 x 5 Gy)
Number of subjects: 1321

Group type: COMPARATOR
Intervention: TME surgery alone
Number of subjects: 1321
Study: 9709267

Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0
Study: 8292066

Group type: EXPERIMENTAL
Intervention: Compressed naproxen suppositories (250 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard naproxen tablet
Number of subjects: 12
Study: 30955977

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks for up to 35 cycles
Number of subjects: 1274

Group type: COMPARATOR
Intervention: Chemotherapy (investigator's choice of platinum-based chemotherapy for four to six cycles)
Number of subjects: 1274
Study: 26924360

Group type: EXPERIMENTAL
Intervention: O-(beta-Hydroxyethyl)-rutosides (Oxerutin), 500 mg po q12hr
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 60
Study: 26252342

Group type: EXPERIMENTAL
Intervention: Combined resistance and endurance training (REG)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resistance training alone (RG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 36
Study: 23004225

Group type: EXPERIMENTAL
Intervention: Nerve stimulation (Group NS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ultrasound guidance (Group US)
Number of subjects: 60
Study: 22035463

Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg once daily
Number of subjects: 1955

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily
Number of subjects: 1955

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily + HCTZ 12.5 mg once daily
Number of subjects: 1955

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg once daily + HCTZ 25 mg once daily
Number of subjects: 1955

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1955
Study: 18465710

Group type: EXPERIMENTAL
Intervention: Beta‐RT (90Sr eye applicator delivering 2500 cGy)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sham irradiation (same applicator without 90Sr)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Beta‐RT
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 81
Study: 17211296

Group type: EXPERIMENTAL
Intervention: 400 ppb ozone
Number of subjects: 0
Study: 14651394

Group type: EXPERIMENTAL
Intervention: Digital rectal examination
Number of subjects: 1225

Group type: EXPERIMENTAL
Intervention: PSA test
Number of subjects: 1225

Group type: COMPARATOR
Intervention: Digital rectal examination or PSA test
Number of subjects: 1225
Study: 11089748

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gel, three times a day during the ICU stay
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard oral care
Number of subjects: 60
Study: 9352276

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 0.1% ophthalmic solution
Number of subjects: 116

Group type: COMPARATOR
Intervention: Prednisolone acetate 1.0% ophthalmic suspension
Number of subjects: 116
Study: 8452179

Group type: EXPERIMENTAL
Intervention: Fleroxacin (400 mg) given as a single dose
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Fleroxacin (400 mg) given once daily for 3 days
Number of subjects: 508

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 508
Study: 3940260

Group type: EXPERIMENTAL
Intervention: Loperamide (12 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31744020

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided central line insertion (US-guided CICC)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Peripherally inserted catheter (PICC)
Number of subjects: 61
Study: 29800622

Group type: EXPERIMENTAL
Intervention: UC + CALM ARC
Number of subjects: 75

Group type: COMPARATOR
Intervention: UC
Number of subjects: 75
Study: 27082519

Group type: EXPERIMENTAL
Intervention: Nasal oxygen insufflation (100 mL/kg/min, estimated 37% FiO2, n = 9)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Room air (estimated 21% FiO2, n = 10)
Number of subjects: 19
Study: 26591103

Group type: EXPERIMENTAL
Intervention: CRON diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 0
Study: 23446899

Group type: EXPERIMENTAL
Intervention: 0.5 kiwifruit/d
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 2 kiwifruit/d
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 20691328

Group type: EXPERIMENTAL
Intervention: New cognitive behavioural treatment
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Behaviour therapy (leading alternative psychological treatment)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Guided self‐help (minimal intervention)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Behaviour therapy
Number of subjects: 150
Study: 17918288

Group type: EXPERIMENTAL
Intervention: Left thoracic RT with EC CT
Number of subjects: 34

Group type: COMPARATOR
Intervention: Right thoracic RT with EC CT
Number of subjects: 34
Study: 15547564

Group type: COMPARATOR
Intervention: Head-on orientation
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Side-on orientation
Number of subjects: 131
Study: 11220440

Group type: EXPERIMENTAL
Intervention: In-group information processing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low cognitive load
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High cognitive load
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Idiographic procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-congruent information attribution
Number of subjects: 0
Study: 9475020

Group type: EXPERIMENTAL
Intervention: Intraoperative 5-FU
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Postoperative 5-FU
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no adjunctive antimetabolites)
Number of subjects: 33
Study: 7947383

Group type: EXPERIMENTAL
Intervention: Nisoldipine (20 mg once daily)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 2828249

Group type: EXPERIMENTAL
Intervention: Monotherapy with theophylline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Monotherapy with terbutaline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of theophylline and terbutaline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31101039

Group type: EXPERIMENTAL
Intervention: Early-initiated home-based sensori-motor training (SMT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Functional exercise training (usual care)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 30509185

Group type: EXPERIMENTAL
Intervention: Specific micronutrient combination
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 26691407

Group type: EXPERIMENTAL
Intervention: Low-intensity plyometric training
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Moderate-intensity plyometric training
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-intensity plyometric training
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combined-intensity plyometric training
Number of subjects: 15
Study: 24721460

Group type: EXPERIMENTAL
Intervention: P4 pain scale
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: WOMAC-pain
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: ICOAP
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: WOMAC-function
Number of subjects: 156
Study: 21937705

Group type: EXPERIMENTAL
Intervention: Vinorelbine/Gemcitabine doublet (VG arm: vinorelbine 25 mg/m2; gemcitabine 1000 mg/m2 on days 1 and 15)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Capecitabine (Cap arm: 1250 mg/m2 twice daily, on days 1-14)
Number of subjects: 148
Study: 20853931

Group type: EXPERIMENTAL
Intervention: ICBT + P
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: TSF + P
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Higher attendance in both groups
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Initial levels of depressive symptomology
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Early treatment response
Number of subjects: 206
Study: 17184890

Group type: EXPERIMENTAL
Intervention: Topiramate (100 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Topiramate (200 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Methamphetamine (15 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Methamphetamine (30 mg)
Number of subjects: 10
Study: 16084254

Group type: EXPERIMENTAL
Intervention: Combination antibiotic susceptibility testing (MCBT)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Conventional culture and sensitivity testing
Number of subjects: 251
Study: 12898820

Group type: EXPERIMENTAL
Intervention: Acute stage of disease (before treatment)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: After clearing of skin lesions (after effective treatment)
Number of subjects: 9
Study: 10511362

Group type: EXPERIMENTAL
Intervention: 2 g/day of elemental calcium
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 7486112

Group type: EXPERIMENTAL
Intervention: Nitroprusside treatment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 1941777

Group type: EXPERIMENTAL
Intervention: Ultraconservative sealed composite restorations (CompS/C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultraconservative sealed amalgam restorations (AGS)
Number of subjects: 0
Study: 7010990

Group type: EXPERIMENTAL
Intervention: Human thromboplastin (British Comparative Thromboplastin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rabbit thromboplastin (Simplastin Automated)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bovine thromboplastin (Thrombotest)
Number of subjects: 0
Study: 31116188

Group type: EXPERIMENTAL
Intervention: 6-mm-long and 4-mm-wide implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Implants at least 10-mm long in augmented bone
Number of subjects: 40
Study: 28318845

Group type: EXPERIMENTAL
Intervention: Positive affect‐oriented communication
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Positive expectations
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Combination of positive affect‐oriented communication and positive expectation
Number of subjects: 293
Study: 25635925

Group type: EXPERIMENTAL
Intervention: Music combined with vibration on acupuncture points
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vibratory stimuli on acupuncture points
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Music only (Bach's compositions)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Complete group (music + vibration + binaural beats)
Number of subjects: 120
Study: 24167605

Group type: EXPERIMENTAL
Intervention: Persistent antenatal Common Mental Disorders (CMD) defined as EPDS-V score ≥ 4 in both W1 and W2
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Incidence of Iron Deficiency Anaemia (IDA) in the third trimester
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Advice to take iron supplements
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Higher household wealth index
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Length of time that iron supplements had been taken
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Early pregnancy IDA
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Being multi-parous
Number of subjects: 378
Study: 21161116

Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (4 contractions of 45 seconds each at 30% of maximal grip strength for 5 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (15 minutes of sitting without exercising for 5 days)
Number of subjects: 18
Study: 19194676

Group type: EXPERIMENTAL
Intervention: Camouflage orthodontics (premolar extraction)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fixed functional orthopedic appliance
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Orthognathic surgery (bilateral sagittal split osteotomy)
Number of subjects: 60
Study: 17763203

Group type: EXPERIMENTAL
Intervention: Indomethacin (75 mg bd)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Rofecoxib (12.5 mg bd)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 15199080

Group type: EXPERIMENTAL
Intervention: Active marijuana (MJ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo marijuana (MJ)
Number of subjects: 0
Study: 11398877

Group type: EXPERIMENTAL
Intervention: Paclitaxel-cisplatin-etoposide (TEP) regimen
Number of subjects: 133

Group type: COMPARATOR
Intervention: Cisplatin-etoposide (EP) regimen
Number of subjects: 133
Study: 9508295

Group type: EXPERIMENTAL
Intervention: PCR assay for Bordetella pertussis
Number of subjects: 2442

Group type: COMPARATOR
Intervention: Cultures for Bordetella pertussis
Number of subjects: 2442

Group type: EXPERIMENTAL
Intervention: Parapertussis PCR using primers BPPA and BPPZ
Number of subjects: 2442
Study: 7659480

Group type: EXPERIMENTAL
Intervention: DTP
Number of subjects: 2342

Group type: EXPERIMENTAL
Intervention: DTaP
Number of subjects: 2342

Group type: EXPERIMENTAL
Intervention: DTP and DTaP
Number of subjects: 2342
Study: 2396471

Group type: EXPERIMENTAL
Intervention: 3 x S (three doses of suspension-formulated vaccine)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 3 x E (three doses of vaccine in enteric-coated capsules)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 2 x S (two doses of suspension-formulated vaccine)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 1 x S (one dose of suspension-formulated vaccine)
Number of subjects: 4
Study: 93180

Group type: EXPERIMENTAL
Intervention: Chlorothiazide
Number of subjects: 0
Study: 30138543

Group type: EXPERIMENTAL
Intervention: Glucocorticoid (20 mg prednisolone)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (20 mg Avicel)
Number of subjects: 9
Study: 26969581

Group type: EXPERIMENTAL
Intervention: Attention training to pleasant (ATP) stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control (PC) condition
Number of subjects: 0
Study: 26462799

Group type: EXPERIMENTAL
Intervention: Discussion board only (arm 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discussion board plus psychoeducation (arm 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discussion board, psychoeducation plus cognitive behavioural therapy-based tools (arm 3)
Number of subjects: 0